159 related articles for article (PubMed ID: 26967219)
1. Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study.
Remington R; Bechtel C; Larsen D; Samar A; Page R; Morrell C; Shea TB
J Alzheimers Dis; 2016; 51(4):991-5. PubMed ID: 26967219
[TBL] [Abstract][Full Text] [Related]
2. A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease.
Remington R; Bechtel C; Larsen D; Samar A; Doshanjh L; Fishman P; Luo Y; Smyers K; Page R; Morrell C; Shea TB
J Alzheimers Dis; 2015; 45(2):395-405. PubMed ID: 25589719
[TBL] [Abstract][Full Text] [Related]
3. A Nutritional Formulation for Cognitive Performance in Mild Cognitive Impairment: A Placebo-Controlled Trial with an Open-Label Extension.
Remington R; Lortie JJ; Hoffmann H; Page R; Morrell C; Shea TB
J Alzheimers Dis; 2015; 48(3):591-5. PubMed ID: 26402075
[TBL] [Abstract][Full Text] [Related]
4. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.
Aisen PS; Schneider LS; Sano M; Diaz-Arrastia R; van Dyck CH; Weiner MF; Bottiglieri T; Jin S; Stokes KT; Thomas RG; Thal LJ;
JAMA; 2008 Oct; 300(15):1774-83. PubMed ID: 18854539
[TBL] [Abstract][Full Text] [Related]
5. Correlations between cognitive, behavioural and psychological findings and levels of vitamin B12 and folate in patients with dementia.
Engelborghs S; Vloeberghs E; Maertens K; Mariën P; Somers N; Symons A; Clement F; Ketels V; Saerens J; Goeman J; Pickut BA; Vandevivere J; De Deyn PP
Int J Geriatr Psychiatry; 2004 Apr; 19(4):365-70. PubMed ID: 15065230
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychological correlates of behavioral symptoms in Alzheimer's disease, frontal variant of frontotemporal, subcortical vascular, and lewy body dementias: a comparative study.
Perri R; Monaco M; Fadda L; Caltagirone C; Carlesimo GA
J Alzheimers Dis; 2014; 39(3):669-77. PubMed ID: 24254701
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study.
Remington R; Chan A; Paskavitz J; Shea TB
Am J Alzheimers Dis Other Demen; 2009; 24(1):27-33. PubMed ID: 19056706
[TBL] [Abstract][Full Text] [Related]
8. Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT.
van der Zwaluw NL; Dhonukshe-Rutten RA; van Wijngaarden JP; Brouwer-Brolsma EM; van de Rest O; In 't Veld PH; Enneman AW; van Dijk SC; Ham AC; Swart KM; van der Velde N; van Schoor NM; van der Cammen TJ; Uitterlinden AG; Lips P; Kessels RP; de Groot LC
Neurology; 2014 Dec; 83(23):2158-66. PubMed ID: 25391305
[TBL] [Abstract][Full Text] [Related]
9. Behavioral and psychological symptoms assessed with the BEHAVE-AD-FW are differentially associated with cognitive dysfunction in Alzheimer's disease.
Ito T; Meguro K; Akanuma K; Meguro M; Lee E; Kasuya M; Ishii H; Mori E
J Clin Neurosci; 2007 Sep; 14(9):850-5. PubMed ID: 17587584
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension.
Chan A; Paskavitz J; Remington R; Rasmussen S; Shea TB
Am J Alzheimers Dis Other Demen; 2008 Dec-2009 Jan; 23(6):571-85. PubMed ID: 19047474
[TBL] [Abstract][Full Text] [Related]
11. The clinical utility of the Mattis Dementia Rating Scale in assessing cognitive decline in Alzheimer's disease.
Miller JM; Pliskin NH
Int J Neurosci; 2006 May; 116(5):613-27. PubMed ID: 16644521
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of the functional independence measure for assessment of patients with Alzheimer's disease and vascular dementia.
Tanaka N; Nakatsuka M; Ishii H; Nakayama R; Hosaka R; Meguro K
Psychogeriatrics; 2013 Dec; 13(4):199-205. PubMed ID: 24289460
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial.
Scheltens P; Kamphuis PJ; Verhey FR; Olde Rikkert MG; Wurtman RJ; Wilkinson D; Twisk JW; Kurz A
Alzheimers Dement; 2010 Jan; 6(1):1-10.e1. PubMed ID: 20129316
[TBL] [Abstract][Full Text] [Related]
14. A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia.
Chan A; Remington R; Kotyla E; Lepore A; Zemianek J; Shea TB
J Nutr Health Aging; 2010 Mar; 14(3):224-30. PubMed ID: 20191258
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of apathy, dysphoria, and depression in relation to dementia severity in Alzheimer's disease.
Landes AM; Sperry SD; Strauss ME
J Neuropsychiatry Clin Neurosci; 2005; 17(3):342-9. PubMed ID: 16179656
[TBL] [Abstract][Full Text] [Related]
16. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.
Feldman HH; Ferris S; Winblad B; Sfikas N; Mancione L; He Y; Tekin S; Burns A; Cummings J; del Ser T; Inzitari D; Orgogozo JM; Sauer H; Scheltens P; Scarpini E; Herrmann N; Farlow M; Potkin S; Charles HC; Fox NC; Lane R
Lancet Neurol; 2007 Jun; 6(6):501-12. PubMed ID: 17509485
[TBL] [Abstract][Full Text] [Related]
17. Association of cerebral emboli with accelerated cognitive deterioration in Alzheimer's disease and vascular dementia.
Purandare N; Burns A; Morris J; Perry EP; Wren J; McCollum C
Am J Psychiatry; 2012 Mar; 169(3):300-8. PubMed ID: 22193532
[TBL] [Abstract][Full Text] [Related]
18. Clinical Benefits of Memantine Treatment for Alzheimer's Disease in the Okayama Memantine Study II (OMS II).
Matsuzono K; Yamashita T; Ohta Y; Hishikawa N; Koike M; Sato K; Kono S; Deguchi K; Nakano Y; Abe K
J Alzheimers Dis; 2015; 47(2):487-93. PubMed ID: 26401570
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial.
Scheltens P; Twisk JW; Blesa R; Scarpini E; von Arnim CA; Bongers A; Harrison J; Swinkels SH; Stam CJ; de Waal H; Wurtman RJ; Wieggers RL; Vellas B; Kamphuis PJ
J Alzheimers Dis; 2012; 31(1):225-36. PubMed ID: 22766770
[TBL] [Abstract][Full Text] [Related]
20. Behavioural and psychological symptoms of Alzheimer type dementia are not correlated with plasma homocysteine concentration.
Tabet N; Rafi H; Weaving G; Lyons B; Iversen SA
Dement Geriatr Cogn Disord; 2006; 22(5-6):432-8. PubMed ID: 16983185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
